Research Priorities - Cancer
  • Article
  • Nov 20 2017

The University of Kentucky Markey Cancer Center is one of 22 cancer centers nationwide to receive funding to build and implement tobacco cessation treatment programs via the National Cancer Institute's Cancer Center Cessation Initiative (CCCI).

  • Article
  • Nov 9 2017

New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.

  • Podcast
  • Nov 9 2017

Kip Guy shares his research on neglected diseases, his goals as dean of the College of Pharmacy, and how pharmacy researchers are addressing the opioid epidemic.

  • Article
  • Nov 2 2017

The University of Kentucky Markey Cancer Center has joined the Oncology Research Information Exchange Network® (ORIEN), a personalized medicine consortium that allows its members to exchange data and push forward evidence-based cancer care to patients.

  • Article
  • Oct 6 2017

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

  • Video
  • Oct 4 2017

What the Kentucky Extension Homemakers began four decades ago continues to make a profound difference in the lives of women across the Commonwealth.

  • Article
  • Sep 29 2017

Many cancer survivors experience devastating cognitive impairment following chemotherapy. Researchers at UK are trying to identify strategies to relieve these symptoms.

  • Article
  • Sep 28 2017

In a new phase III trial report, recurrence and survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy & chemotherapy when compared with pelvic radiation therapy.

  • Video
  • Aug 24 2017

Kip Guy, Pharmacy Dean, is discovering and developing new drugs for neglected diseases.

  • Article
  • Aug 4 2017

A new study by University of Kentucky Markey Cancer Center researchers shows that when therapy-sensitive cancer cells die, they release a "killer peptide" that can eliminate therapy-resistant cells.